Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria
<p><strong>Background</strong> Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites, but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a treatment termed “radical cure”). Tafenoquine is a single-dose 8-aminoquinoline th...
المؤلفون الرئيسيون: | Lacerda, MVG, Llanos-Cuentas, A, Krudsood, S, Lon, C, Saunders, DL, Mohammed, R, Yilma, D, Batista Pereira, D, Espino, FEJ, Mia, RZ, Chuquiyauri, R, Val, F, Casapía, M, Monteiro, WM, Brito, MAM, Costa, MRF, Buathong, N, Noedl, H, Diro, E, Getie, S, Wubie, KM, Abdissa, A, Zeynudin, A, Abebe, C, Tada, MS, Brand, F, Beck, H-P, Angus, B, Duparc, S, Kleim, J-P, Kellam, LM, Rousell, VM, Jones, SW, Hardaker, E, Mohamed, K, Clover, DD, Fletcher, K, Breton, JJ, Ugwuegbulam, CO, Green, JA, Koh, GCKW |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Massachusetts Medical Society
2019
|
مواد مشابهة
-
Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
حسب: Llanos-Cuentas, A, وآخرون
منشور في: (2019) -
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
حسب: St Jean, PL, وآخرون
منشور في: (2020) -
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
حسب: Watson, JA, وآخرون
منشور في: (2022) -
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
حسب: Watson, JA, وآخرون
منشور في: (2024) -
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
حسب: Mark M Fukuda, وآخرون
منشور في: (2017-01-01)